Literature DB >> 27239763

Hepatocyte mitochondrial DNA released in microparticles and toll-like receptor 9 activation: A link between lipotoxicity and inflammation during nonalcoholic steatohepatitis.

Maria Eugenia Inzaugarat1, Alexander Wree1,2, Ariel E Feldstein2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27239763      PMCID： PMC4956555          DOI： 10.1002/hep.28666

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  8 in total

1.  Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9.

Authors:  Irma Garcia-Martinez; Nicola Santoro; Yonglin Chen; Rafaz Hoque; Xinshou Ouyang; Sonia Caprio; Mark J Shlomchik; Robert Lee Coffman; Albert Candia; Wajahat Zafar Mehal
Journal:  J Clin Invest       Date:  2016-01-25       Impact factor: 14.808

Review 2.  Hepatic inflammation and fibrosis: functional links and key pathways.

Authors:  Ekihiro Seki; Robert F Schwabe
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

Review 3.  Management of NAFLD: a stage-based approach.

Authors:  Mary E Rinella; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

Review 4.  Pathogenesis of Nonalcoholic Steatohepatitis.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

Review 5.  Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.

Authors:  Karima Begriche; Julie Massart; Marie-Anne Robin; Fabrice Bonnet; Bernard Fromenty
Journal:  Hepatology       Date:  2013-08-07       Impact factor: 17.425

6.  Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis.

Authors:  Yoon Seok Roh; Surim Park; Jong Won Kim; Chae Woong Lim; Ekihiro Seki; Bumseok Kim
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

7.  Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ.

Authors:  Davide Povero; Nadia Panera; Akiko Eguchi; Casey D Johnson; Bettina G Papouchado; Lucas de Araujo Horcel; Eva M Pinatel; Anna Alisi; Valerio Nobili; Ariel E Feldstein
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-11-01

Review 8.  Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis.

Authors:  Davide Povero; Ariel E Feldstein
Journal:  Diabetes Metab J       Date:  2016-02       Impact factor: 5.376
  8 in total
  4 in total

1.  Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  Kyle S McCommis; Wesley T Hodges; Elizabeth M Brunt; Ilke Nalbantoglu; William G McDonald; Christopher Holley; Hideji Fujiwara; Jean E Schaffer; Jerry R Colca; Brian N Finck
Journal:  Hepatology       Date:  2017-03-30       Impact factor: 17.425

2.  MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH.

Authors:  Hong Gao; Zhongmou Jin; Gautam Bandyopadhyay; Karina Cunha E Rocha; Xiao Liu; Huayi Zhao; Dinghong Zhang; Hani Jouihan; Soheil Pourshahian; Tatiana Kisseleva; David A Brenner; Wei Ying; Jerrold M Olefsky
Journal:  Cell Metab       Date:  2022-06-13       Impact factor: 31.373

Review 3.  The Emerging Roles of Microparticles in Diabetic Nephropathy.

Authors:  Chen Chen Lu; Kun Ling Ma; Xiong Zhong Ruan; Bi Cheng Liu
Journal:  Int J Biol Sci       Date:  2017-09-05       Impact factor: 6.580

Review 4.  Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver.

Authors:  Sabine Mihm
Journal:  Int J Mol Sci       Date:  2018-10-10       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.